Clinical trial
A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With…
NCT00092079 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092079 |
|---|---|
| Title | A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) |
| Official title | A 15-Week, Double-Blind, Randomized, Active-Controlled, Multi-Center Study With 24-Week Extension to Evaluate the Safety, Tolerability, Efficacy of Alendronate 70 mg Plus Vitamin D3 2800 IU Combination Tablet in Men and Postmenopausal Women With Osteoporosis |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Vitamin D Deficiency |
| Intervention type | Drug |
| Interventions | MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weeks |
| Enrollment | 652 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Sep 24, 2004 |
| Last update posted | Nov 11, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: